Thailand Diabetes Registry Project: Prevalence of diabetic retinopathy and associated factors in type 1 diabetes mellitus

Journal of the Medical Association of Thailand

Volumn 89, Issue SUPPL. 1, 2006, Pages

  Chetthakul, Thanya ^a,k   Likitmaskul, Supawadee ^b   Plengvidhya, Nattachet ^b   Suwanwalaikorn, Sompongse ^c   Kosachunhanun, Natapong ^d   Deerochanawong, Chaicharn ^a,d   Krittiyawong, Sirinate ^e   Leelawatana, Rattana ^f   Benjasuratwong, Yupin ^g   Bunnag, Pongamorn ^h   Prathipanawatr, Thongchai ⁱ   Ngarmukos, Chardpraorn ^h   Mongkolsomlit, Sirima ^l   Rawdaree, Petch ^j  

^a MAHARAT NAKHON RATCHASIMA HOSPITAL   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

^c CHULALONGKORN UNIVERSITY   (Thailand)

^d Faculty of Medicine Chiang Mai University   (Thailand)

^e Theptarin General Hospital   (Thailand)

^f PRINCE OF SONGKLA UNIVERSITY   (Thailand)

^g Phramongkutklao Hospital   (Thailand)

^h MAHIDOL UNIVERSITY   (Thailand)

ⁱ KHON KAEN UNIVERSITY   (Thailand)

^j NAVAMINDRADHIRAJ UNIVERSITY   (Thailand)

^k Department of Medicine   (Thailand)

^l NONE

more..

Author keywords

Diabetic retinopathy; Type 1 diabetes

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FIBRIC ACID DERIVATIVE; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; ORAL ANTIDIABETIC AGENT; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; AGED; ARTICLE; BODY MASS; CHILD; CIGARETTE SMOKING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETIC RETINOPATHY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; METABOLIC REGULATION; MICROALBUMINURIA; MULTICENTER STUDY; PREVALENCE; PROTEINURIA; REGISTER; RETINA EXAMINATION; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; TERTIARY HEALTH CARE; THAILAND; TRIACYLGLYCEROL BLOOD LEVEL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; CREATININE; CROSS-SECTIONAL STUDIES; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 1; DIABETIC RETINOPATHY; FEMALE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; REGISTRIES; RISK FACTORS; THAILAND;

EID: 33845385891     PISSN: 01252208     EISSN: 01252208     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Klein R, Klein BE, Moss SE, David MD, DeMets DL. The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Opthalmol 1984; 102: 520-6.
2. Sjolie AK, Stephenson J, Aldington S, Kohner E, Janka H, Stevens L, et al. Retinopathy and vision loss in insulin-dependent diabetes in Europe. The EURODIAB IDDM Complication Study. Ophthalmology 1997; 104: 252-60.
3. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003; 26(Suppl 1): S5-20.
4. Wilkinson CP, Ferris FL III, Klein RE, Lee PP, Agardh CD, Davis M, et al. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 2003; 110: 1677-82.
5. Chew EY. A simplified diabetic retinopathy scale. Ophthalmology 2003; 110: 1675-6.
6. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care 2005; 28(Suppl 1): S4-36.
7. Nitiyanant W, Tandhanand S, Mahtab H, Zhu XX, Pan CY, Reheja BS, et al. The Diabcare-Asia 1998 study outcomes on control and complications in type 1 and type 2 diabetic patients. Curr Med Res Opin 2002; 18: 317-27.
8. Nitiyanant W, Vannasaeng S, Vichayanrat A, Sriussadaporn S, Piraphatdist T, Singalavanija A. Vascular complications and lipid disorders in IDDM in Thailand. Constitutional Med 1992; 55(Suppl): S134-7.
9. Deerochanawong C, Kornthong P, Ngawngamrat S, Sunthontepvarakul T, Sarinnapakorn V, Serirat S. Microvascular and acute complications in IDDM patients. The Endocrine Society of Thailand 8th Annual Meeting, Bangkok Thailand, 1996.
10. Malone JI, Morrison AD, Pavan PR, Cuthbertson DD. Prevalence and significance of retinopathy in subjects with type 1 diabetes of less than 5 years' duration screened for the diabetes control and complications trial. Diabetes Care 2001; 24: 522-6.
11. Marshall G, Garg SK, Jackson WE, Holmes D, Chase HP. Factors influencing the onset and progression of diabetic retinopathy in subjects with insulin-dependent diabetes mellitus. Ophthalmology 1993; 100: 1133-9.
12. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-86.
13. The Diabetes Control and Complications Trial Research Group. Early worsening of diabetic retinopathy in the Diabetes Control and Complications Trial. Arch Ophthalmol 1998; 116: 874-86.
14. Klein BE, Moss SE, Klein R, Surawicz TS. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XIII. Relationship of serum cholesterol to retinopathy and hard exudates. Ophthalmology 1991; 98: 1261-5.
15. Moss SE, Klein R, Klein BE. Cigarette smoking and ten-year progression of diabetic retinopathy. Ophthalmology 1996; 103: 1438-42.
16. Cohen RA, Hennekens CH, Christen WG, Krolewski A, Nathan DM, Peterson MJ, et al. Determinants of retinopathy progression in type 1 diabetes mellitus. Am J Med 1999; 107: 45-51.